MedTrace Logo

Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment

NCT00929357 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 156

Last updated 2011-08-10

Study results available
· View outcomes & findings →

Summary

This study involves review and analysis of disease activity in patients with rheumatoid arthritis who where treated with either conventional DMARDs (Disease Modifying Antirheumatic Drugs) or Biologics and have two existing, consecutive radiographs (x-ray images) of hand and feet taken as part of routine treatment monitoring within a time interval of 12 to 36 months.

Conditions

Interventions

DRUG

DMARDs or Biologics

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Wyeth is now a wholly owned subsidiary of Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-06-30
Completion
2010-06-30

Countries

  • Denmark

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00929357 on ClinicalTrials.gov